Meeting Name: Committee on Health Agenda status: Final
Meeting date/time: 9/20/2023 10:00 AM Minutes status: Final  
Meeting location: Council Chambers - City Hall
Jointly with the Committee on Hospitals
Published agenda: Agenda Agenda Published minutes: Minutes Minutes  
Meeting video:  
Attachments: CLICK ANY FILE # BELOW (in blue) TO ACCESS LEGISLATION AND ATTACHMENTS
File #Ver.Prime SponsorAgenda #Agenda NoteNameTypeSummaryActionResultAction DetailsMultimedia
            Roll call Not available
T2023-3955 *   Oversight - Evaluating Access to Sickle Cell Care in NYC.Oversight Hearing Held by Committee  Action details Not available
T2023-3955 *   Oversight - Evaluating Access to Sickle Cell Care in NYC.Oversight Filed, by Committee  Action details Not available
Res 0771-2023 *Mercedes Narcisse  Sickle Cell Treatment Act. (S1839A/A2609 and S1890/A2661)Resolution Hearing Held by Committee  Action details Not available
Res 0771-2023 *Mercedes Narcisse  Sickle Cell Treatment Act. (S1839A/A2609 and S1890/A2661)Resolution Laid Over by Committee  Action details Not available
Int 0968-2023 *Mercedes Narcisse Proposed Int. No. 968-AEstablishing guidance to improve health outcomes for individuals affected by sickle cell disease.IntroductionThis bill would require the Department of Health and Mental Hygiene, in consultation with New York City Health and Hospitals, to create guidance to educate medical professionals and the public on the detection of the sickle cell trait through pre- and post-conception genetic screening and on the management and treatment of sickle cell disease. Guidance for medical professionals is required to include education on the benefits of recommending screenings during the family planning process and on nondiscriminatory approaches to assess patient pain, including instruction on implicit bias in the provision of pain management. The bill would also require that pre- and post- conception genetic screening for sickle cell trait be offered to those who fall into an at-risk population or for whom such screening is otherwise medically recommended.Hearing Held by Committee  Action details Not available
Int 0968-2023 *Mercedes Narcisse  Establishing guidance to improve health outcomes for individuals affected by sickle cell disease.IntroductionThis bill would require the Department of Health and Mental Hygiene, in consultation with New York City Health and Hospitals, to create guidance to educate medical professionals and the public on the detection of the sickle cell trait through pre- and post-conception genetic screening and on the management and treatment of sickle cell disease. Guidance for medical professionals is required to include education on the benefits of recommending screenings during the family planning process and on nondiscriminatory approaches to assess patient pain, including instruction on implicit bias in the provision of pain management. The bill would also require that pre- and post- conception genetic screening for sickle cell trait be offered to those who fall into an at-risk population or for whom such screening is otherwise medically recommended.Amendment Proposed by Comm  Action details Not available
Int 0968-2023 *Mercedes Narcisse  Establishing guidance to improve health outcomes for individuals affected by sickle cell disease.IntroductionThis bill would require the Department of Health and Mental Hygiene, in consultation with New York City Health and Hospitals, to create guidance to educate medical professionals and the public on the detection of the sickle cell trait through pre- and post-conception genetic screening and on the management and treatment of sickle cell disease. Guidance for medical professionals is required to include education on the benefits of recommending screenings during the family planning process and on nondiscriminatory approaches to assess patient pain, including instruction on implicit bias in the provision of pain management. The bill would also require that pre- and post- conception genetic screening for sickle cell trait be offered to those who fall into an at-risk population or for whom such screening is otherwise medically recommended.Laid Over by Committee  Action details Not available
            Not available